Roche Canada, the leading personalized healthcare brand, recently launched 'The New Pap,' an at-home HPV DNA test. The brand is targeting both Millennial and Gen Z women with relatable, playful messaging that reminds them that their grandmothers, their second-grade teachers, and their aunt's friends have all had a PAP test. Especially since 75% of sexually active Canadians will get HPV at least once and almost all cases of cervical cancer are caused by HPV.
The New Pap is different than a typical Pap test that's been used for over 70 years by analyzing abnormal changes in cervical cells. The New Pap is an HPV DNA test that detects DNA of high-risk HPV in cervical cells through modern ab technology to analyze a woman’s risk for pre-cancer or cancer.
At-Home HPV DNA Test
The New Pap Determines a Woman’s Risk for Pre-cancer or Cancer
Trend Themes
1. At-home HPV DNA Test - Disruptive innovation opportunity: Develop user-friendly and convenient at-home HPV DNA tests for early detection of cervical cancer.
2. Personalized Healthcare Brand - Disruptive innovation opportunity: Create personalized healthcare brands that target specific demographics with relatable and playful messaging.
3. Use of HPV DNA Test for Risk Assessment - Disruptive innovation opportunity: Develop advanced HPV DNA tests that accurately assess a woman's risk for pre-cancer or cancer.
Industry Implications
1. Healthcare - Disruptive innovation opportunity: Integrate technology and home testing kits into the healthcare industry for improved accessibility and convenience.
2. Genetic Testing - Disruptive innovation opportunity: Expand genetic testing technologies to include HPV DNA tests for early detection of cervical cancer.
3. Pharmaceuticals - Disruptive innovation opportunity: Develop targeted pharmaceutical treatments based on the results of HPV DNA tests for personalized cancer treatment.